Likewise, Miyachi et al. showed that neutralizing antibody against another VCAM-1 ligand ITGα4 inhibited adhesion and migration of monocytes and improved liver inflammation in murine NASH model, further implicating VCAM-1 in the inflammatory process in NASH pathogenesis [55]. This evidence concerns the gene VCAM1 and metabolic dysfunction-associated steatohepatitis.